Specialist Updates 
Cardiology

Evidence mounts on safety of RAS blockade in COVID-19

A meta-analysis provides ‘solid evidence’ that common antihypertensives do not worsen outcomes, researchers say
Clare Pain
0
8 July 2020
Save
senior man in mask having his BP taken by a nurse

Most people with hypertension will be safe to stay on their renin-angiotensin system (RAS) blockers if they develop COVID-19, according to a meta-analysis.

Italian researchers pooled data from 10 observational studies to see whether people on the antihypertensives were more at risk of severe or fatal COVID-19 than patients with hypertension who were not taking the drugs.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .